L Jay Katz
Overview
Explore the profile of L Jay Katz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
2496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
22.
Tran E, Sanvicente C, Hark L, Myers J, Zhang Q, Shiuey E, et al.
Eur J Ophthalmol
. 2021 May;
32(3):1538-1546.
PMID: 34041935
Purpose: To determine the efficacy of an educational intervention on patient adoption and attitudes toward selective laser trabeculoplasty (SLT) as first-line treatment for glaucoma. Methods: This study is a randomized...
23.
Leiby B, Hegarty S, Zhan T, Myers J, Katz L, Haller J, et al.
Prev Chronic Dis
. 2021 May;
18:E52.
PMID: 34014814
Introduction: Appointment nonadherence is common among people with glaucoma, making it difficult for eye care providers to monitor glaucoma progression. Our objective was to determine whether the use of patient...
24.
Samuelson T, Singh I, Williamson B, Falvey H, Lee W, Odom D, et al.
Am J Ophthalmol
. 2021 Mar;
229:220-229.
PMID: 33737036
Objective: To assess quality of life (QOL) as measured by patient-reported outcomes (PRO) within the iStent inject® pivotal trial. Design: Randomized controlled trial analysis of secondary outcomes. Methods: The Vision...
25.
Ahmed O, Waisbourd M, Spaeth G, Katz L
Surv Ophthalmol
. 2020 Dec;
66(4):644-652.
PMID: 33316283
Glaucoma is characterized by retinal ganglion cell loss that can lead to permanent visual loss. Current clinical management practice assumes that glaucomatous visual loss is irreversible; however, there is increasing...
26.
Shalaby W, Bechay J, Myers J, Lee D, Razeghinejad R, Nayak Kolomeyer N, et al.
J Cataract Refract Surg
. 2020 Dec;
47(7):886-891.
PMID: 33315736
Objective: To describe reoperations that occurred within 90 days of minimally invasive glaucoma surgery (MIGS) at a single institution over a 30-month period. Setting: Tertiary care hospital. Design: Retrospective case...
27.
Konstas A, Schmetterer L, Katsanos A, Hutnik C, Hollo G, Quaranta L, et al.
Adv Ther
. 2020 Oct;
38(1):24-51.
PMID: 33108623
The key clinical attributes of preserved dorzolamide/timolol fixed combination (DTFC) and the emerging potential of preservative-free (PF) DTFC are reviewed with published evidence and clinical experience. The indications and role...
28.
Lin M, Moster S, Zheng C, Anderson-Quinones C, Katz L, Pro M, et al.
Ophthalmol Glaucoma
. 2020 Oct;
3(4):306-308.
PMID: 33008565
No abstract available.
29.
Shalaby W, Myers J, Razeghinejad R, Katz L, Pro M, Dale E, et al.
Ophthalmol Glaucoma
. 2020 Sep;
4(2):182-192.
PMID: 32956898
Purpose: To determine the outcomes of Ahmed glaucoma valve (AGV; New World Medical Inc) and Baerveldt glaucoma implant (BGI; Advanced Medical Optics) surgery in the setting of neovascular glaucoma (NVG)....
30.
Razeghinejad R, Gonzalez-Garcia A, Myers J, Katz L
J Glaucoma
. 2020 Sep;
30(1):17-23.
PMID: 32941320
Precis: The VisuALL head-mounted perimetry in normal subjects and glaucoma patients had a moderate to strong correlation with the Humphrey Field Analyzer (HFA). Purpose: Visual field testing has a vital...